Aimei Health Technology Co. Ltd
AFJK | NASDAQ
$12.01
+$0.01 (+0.08%)
Sep 22, 2026, 3:59 PM ET · Market open
Company Profile
Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries. Aimei Health Technology Co., Ltd. was established in 2023 and is based in New York, New York.
Key Executives
| Name | Position |
|---|---|
| Junheng Xie | Chief Executive Officer, Secretary & Director |
| Heung Ming Wong | Chief Financial Officer & Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 03, 2026 | 8-K | Current Report |
| Aug 25, 2026 | 8-K | Current Report |
| Aug 13, 2026 | 10-Q | Quarterly Report |
| Aug 10, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 06, 2026 | 8-K | Current Report |
| Aug 05, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jul 08, 2026 | 8-K | Current Report |
| Jul 06, 2026 | 8-K | Current Report |
| Jul 01, 2026 | 3 | Filing |
| Jun 29, 2026 | 8-K | Current Report |
Aimei Health Technology Co. Ltd
| Country | United States |
| IPO Date | Jan 21, 2024 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | 2 |
| CEO | Junheng Xie |
Contact Details
10 East 53rd Street New York City,
New York 10022 United States
Stock Details
| Ticker Symbol | AFJK |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001979005 |
| CUSIP Number | G01341109 |
| ISIN Number | KYG013411098 |
| SIC Code | 6770 |
Add to Watchlist
Select watchlists to add or remove AFJK